Epidiolex Sales Drive GW Pharma’s $68 Million Revenue in Q2

New Cannabis Ventures
By NCV NewswireAug 6, 2019, 4:32 pm143 pts
GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2019 Epidiolex U.S. Q2 net sales of $68.4 million Positive CHMP opinion clears way for an expected European approval in October Conference call today at 4:30 p.m. EST CARLSBAD, Calif., Aug. 06,…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Federal Court Sides With Safe Drug Consumption Site, Saying Religious Protections Apply 79

Chicagoland Cookies Dispensary Opens in Illinois 79

Texas lawmaker introduces longshot marijuana legalization proposal 79

‘Mayor of Oaksterdam’ Richard Lee passes 79

How many legal marijuana stores can New York’s $1.5 billion market support? 77

AYR Wellness Further Extends Limited Waiver Agreement With Senior Noteholders 75

High Rollers Gysyng, Sunnytein Cannabis Lounges Open Quietly 75

Bipartisan Coalition of 32 Attorneys General Call for Federal Cannabis Banking Reforms 74

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.